Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00096447 · COMPLETED

Trial details

NCT number: NCT00096447
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Endometrial Carcinoma

Start date: 2004-11-01
Primary completion: 2011-03-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.